Over the years, the brain of a Parkinson's patient adapts to ... "It's like an orchestra where the conductor goes on vacation," said Stephen Cowen, senior author of the study and an associate ...

TD Cowen analyst Ritu Baral maintained a Buy rating on Praxis Precision Medicines (PRAX – Research Report) today and set a price target of ...

An online program aimed at improving diet, exercise and other modifiable risk factors for dementia has resulted in better cognition in older adults, Australian research has found.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...

Former president Joe Biden once suggested that misinformation is “killing people.” As far back as the 2016 election, exposure ...

Over the years, the brain of a Parkinson's patient adapts to ... "It's like an orchestra where the conductor goes on vacation," said Stephen Cowen, senior author of the study and an associate ...

He's the brain of the line.' It's a huge step forward ... showing how important he was to the team in their victory over Cowan's squad. A lot of noise has come about with regards to Easton Cowan ...

“Perhaps market fears are overdone, and consumers will keep eating and drinking like they always have,” Cowen’s Robert Moskow said. “But our business brain can’t get comfortable with the ...

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are covering the stock, MarketBeat.com reports. One ...